Last reviewed · How we verify
FLOT-CROSS or CROSS-FLOT — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
FLOT-CROSS or CROSS-FLOT (FLOT-CROSS or CROSS-FLOT) — Erasmus Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| FLOT-CROSS or CROSS-FLOT TARGET | FLOT-CROSS or CROSS-FLOT | Erasmus Medical Center | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- FLOT-CROSS or CROSS-FLOT CI watch — RSS
- FLOT-CROSS or CROSS-FLOT CI watch — Atom
- FLOT-CROSS or CROSS-FLOT CI watch — JSON
- FLOT-CROSS or CROSS-FLOT alone — RSS
Cite this brief
Drug Landscape (2026). FLOT-CROSS or CROSS-FLOT — Competitive Intelligence Brief. https://druglandscape.com/ci/flot-cross-or-cross-flot. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab